SecBot SecBot

CUVL

Clinuvel Pharmaceuticals Ltd
Nasdaq· CIK 0001290877 Biotech & Drug Discovery
$4.96 +0.02 (+0.40%)
Oct 26 4:00 PM ET · prev $4.94
Market cap
$251.8M
Micro cap
1 year
−32.6%
from $7.36 · Oct 27
30 days
−13.7%
from $5.75
52-week range
$4.94–8.75
−43% from high · low Oct 23
Avg volume 20D
6.3K
Oct 22 spike 23.8K
Short interest
🔒 Subscribers only
Filing reports
8
analyzed by SecBot
SecBot read MIXED 7 reports · 90 days
Balance 0 bearish · 0 bullish · 1 mixed · 6 neutral oldest → newest, height = score
Avg score ·High conf. 5/7
Strongest NEUTRAL Clinuvel Pharmaceuticals announced that new patient cases from its CUV105 trial of SCENESSE (afamelanotide)…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • TrendDOWNTREND

    17% below its 50-day average. New closing low $4.94 on Oct 23.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 15, 2026 SEC
Clinuvel Pharmaceuticals filed a Form 6-K with the SEC on October 15, 2026, furnishing an Appendix 3H notification of…
6-K — Impact 2/10
Oct 7, 2026 SEC
Clinuvel Pharmaceuticals Ltd filed a Form 6-K with the SEC on October 7, 2026, reporting that on October 5, 2026, it…
6-K — Impact 2/10
Oct 2, 2026 SEC
Clinuvel Pharmaceuticals filed a Form 6-K with the SEC on October 2, 2026, to report that it had filed its Notice of…
6-K — Impact 2/10
Sep 21, 2026 Reg SHO
Reg SHO Threshold: CUVL exited the threshold list
CLINUVEL PHARMACEUTICALS LTD S | On list since 2026-09-11

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Trading halts
Aug 27, 2026Volatility PauseResumed
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 21, 2026
Reg SHO list
Reg SHO Threshold: CUVL exited the threshold list
CLINUVEL PHARMACEUTICALS LTD S | On list since 2026-09-11
Sep 11, 2026
Reg SHO list
Reg SHO Threshold: CUVL entered the threshold list
CLINUVEL PHARMACEUTICALS LTD S | 5+ consecutive settlement days of fails-to-deliver ≥10k shares and ≥0.5% of shares outstanding
Aug 27, 2026
Trading halt
Halt Resumed: CUVL — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-08-27T13:48:11.000Z | Resumed 2026-08-27T13:53:11.000Z
Aug 27, 2026
Trading halt
Trading Halt: CUVL — LUDP (Volatility Trading Pause)
Clinuvel Pharmaceutical ADS | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Aug 27, 2026
Earnings
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion
CLINUVEL PHARMACEUTICALS LTD announced its tenth consecutive annual profit and further rise in free cash in the financial year ended 30 June 2026…

SecBot reports

8 filings · 0 bullish · 0 bearish · 2 mixed · 6 neutral
All CUVL filing & press-release reports (8)